Dr. Mullen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 SW Ramsey Ave
Grants Pass, OR 97527Phone+1 541-472-7040
Education & Training
University of WashingtonResidency, Radiation Oncology, 2013 - 2017
Tufts University/Hallmark Health SystemInternship, Transitional Year, 2012 - 2013- Clemson University Calhoun Honors CollegeBS, Biochemistry, 1999 - 2013
Medical University of South CarolinaClass of 2012
Certifications & Licensure
OR State Medical License 2017 - 2025
WA State Medical License 2013 - 2018
MA State Medical License 2012 - 2013- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 158 citationsCeramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell DeathThomas D. Mullen, Lina M. Obeid
Anti-Cancer Agents in Medicinal Chemistry. 2012-05-01 - 243 citationsA house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathTarek A. Taha, Thomas D. Mullen, Lina M. Obeid
Biochimica Et Biophysica Acta. 2006-11-01 - 99 citationsSelective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolismThomas D. Mullen, Stefka D. Spassieva, Russell W. Jenkins, Kazuyuki Kitatani, Jacek Bielawski
Journal of Lipid Research. 2011-01-01
Grant Support
- Ceramide Synthases Cers5 And Cers6 Regulate Pathways Of Programmed Cell DeathNational Institute Of Environmental Health Sciences2008–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
